Pulmonary lymphangioleiomyomatosis;Pulmonale lymphangioleiomyomatose

Pneumologie

Volumn 56, Issue 5, 2002, Pages 309-315

  Costabel, U ^a   Guzman, J ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

CHYLOTHORAX; CLINICAL FEATURE; DYSPNEA; EPILEPSY; HEMANGIOFIBROMA; HEMOPTYSIS; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; MENTAL DEFICIENCY; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THORAX RADIOGRAPHY; TUBEROUS SCLEROSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036277125     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-30701     Document Type: Review

References (48)

1. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis
2. Pulmonary lymphangioleiomyomatosis in a man
3. Lymphangioleiomyomatosis: Abdominopelvic CT and US findings
4. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas
5. Pulmonary lymphangiomyomatosis. Three new cases studied with electron microscopy
6. How common are renal angiomyolipomas in patients with lymphangioleiomyomatosis?
7. Accuracy of high-resolution CT in diagnosing lung disease
8. Transbronchial biopsy in lymphangioleiomyomatosis of the lung: HMB-45 for diagnosis
9. Steroid receptors in pulmonary lymphangioleiomyomatosis
10. A case of chylous effusion due to leiomyosarcoma
11. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomytosis
12. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis
13. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma
14. Pulmonary lymphangiomyomatosis. A review
15. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex
16. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis
17. Pulmonary lymphangioleiomyomatosis: With particular reference to steroid-receptor assay studies and pathologic correlation
18. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors in pulmonary lymphangioleiomytomatosis
19. Lymphangioleiomyomatosis: Clinical features, management and basic mechanisms
20. Decline in lung function in lymphangioleiomyomatosis. Relation to menopause and progesterone treatment
21. Clinical experince of lymphangioleiomyomatosis in the UK
22. Pulmonary lymphangioleiomyomatosis: High-resolutin CT findings
23. Pulmonary lymphangioleiomyomatosis. A Report of 46 patients including a clinicopathologic study of prognostic factors
24. Dysembryomes metatypiques des reins: Carcinose submiliaire aigue du poumon avec emphyseme generalise et double pneumothorax
25. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study
26. Extrapulmonary lymphangioleiomoymatosis (LAM): Clincopathologic features in 22 cases
27. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis
28. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis
29. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis
30. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex
31. Meningiomas in lymphangioleiomyomatosis
32. Klinik und genetik der tuberösen sklerose
33. Micronodular hyperplasia of type II pneumocytes - A new lung lesion associated with tuberous sclerosis
34. A case of diffuse myomatosis and cyst formation in the lung
35. Lymphangiectasie pulmonaire diffuse, pneumonie chyleuse et chylothorax, après thrombose puerpérale de la veine sous-clavière gauche
36. Clinical and genetic aspects of tuberous sclerosis complex I and II
37. Pulmonary lymphangiomyomatosis
38. Evidence that lymphangioleiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangioleiomyomatosis
39. Lymphangioleiomyomatosis
40. Diagnosis of pulmonaray lymphangioleiomyomatosis by HMB-45 in surgically treated spontaneous pneumothorax
41. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis
42. Lymphangioleiomyomatosis. Clinical course in 32 patients
43. Histopathologic studies on lymphangioleiomyomatosis
44. Lung transplantation: Special considerations and outcome in LAM
45. Pulmonary lymphangioliomyomatosis. A study of 69 patients
46. Über musculäre Cirrhose der Lunge
47. Relation of pulmonary lymphangioleiomyomatosis to use of the oral contraceptive pill and fertility in the UK: A national case control study
48. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis